Figure 2.
Adverse events. Maximum hematologic toxicity as determined by Cochran–Armitage test for trend over all levels of toxicity for patients treated with anti-B4-bR versus observation.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.